000 | 01630 a2200457 4500 | ||
---|---|---|---|
005 | 20250516140359.0 | ||
264 | 0 | _c20130827 | |
008 | 201308s 0 0 eng d | ||
022 | _a1545-5017 | ||
024 | 7 |
_a10.1002/pbc.24507 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYamada, Kayo | |
245 | 0 | 0 |
_aFeasibility of reduced-intensity allogeneic stem cell transplantation with imatinib in children with philadelphia chromosome-positive acute lymphoblastic leukemia. _h[electronic resource] |
260 |
_bPediatric blood & cancer _cAug 2013 |
||
300 |
_aE60-2 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aBenzamides _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPhiladelphia Chromosome |
650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xtherapy |
650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aTransplantation, Homologous |
700 | 1 | _aYasui, Masahiro | |
700 | 1 | _aKondo, Osamu | |
700 | 1 | _aSato, Maho | |
700 | 1 | _aSawada, Akihisa | |
700 | 1 | _aKawa, Keisei | |
700 | 1 | _aInoue, Masami | |
773 | 0 |
_tPediatric blood & cancer _gvol. 60 _gno. 8 _gp. E60-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/pbc.24507 _zAvailable from publisher's website |
999 |
_c22560454 _d22560454 |